Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant RBP-01 in Primary Uveal Melanoma
NCT07747935Phase 2Not yet recruiting
- Sponsor
- ReBio Pharma
- Start
- Oct 2026
- Primary completion
- Apr 2028
01
Overview
A Phase 2 trial of sotrastaurin in Uveal melanoma (UM), sponsored by ReBio Pharma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
sotrastaurin
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT07747935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747935.